IRVING, Texas, Dec. 8, 2015 /PRNewswire/ -- Keneric Healthcare is pleased to see that Exuro Medical, LLC and Hydrofera, LLC have reached a settlement in connection to their respective dispute involving US Patent 6,183,764. Keneric Healthcare understands this releases Exuro Medical, LLC from any claim by Hydrofera, LLC in respect of its above mentioned patent - an agreement apparently struck between those two companies.
"For the avoidance of doubt, Exuro Medical, LLC is not and was not a current distributor for Keneric Healthcare and had not distributed the RTD® range of products for a considerable time," said Al Henry, CEO of Keneric Healthcare.
"Our team of technical and legal experts also remains very confident that RTD® does not and cannot be held to infringe Hydrofera, LLC's relevant patent. Careful and significant analysis has substantiated the position we have always held," Mr. Henry added.
Gordon Wood, President, said, "Keneric Healthcare has continued its strategic growth and is now successfully commercializing its technology in a number of overseas markets. We are incredibly proud of our cornerstone RTD® technology and are looking forward to launching a number of additional product lines in 2017. We remain steadfast in our dedicated and vigorous defense of proceedings brought by Hydrofera, LLC and are extremely confident of a successful outcome."
Keneric Healthcare recently bolstered its capacity to sustain growth by securing further private equity funding from its largest stakeholder, Australian-based Keneric Medical Supplies Pty Ltd, part of the Keneric Group of Companies.
SOURCE Keneric Healthcare